Si-Bone (SIBN) Net Equity Issued and Repurchased (2020 - 2023)
Si-Bone's (SIBN) quarterly Net Equity Issued and Repurchased came in at -$466000.0 in Q3 2023, down 100.65% quarter-over-quarter from $71.6 million in Q4 2020.
Si-Bone (SIBN) Net Equity Issued and Repurchased (2020 - 2023) Analysis & Trends
Si-Bone's Net Equity Issued and Repurchased history runs 2 years deep, the most recent figure standing at -$466000.0 for Q3 2023.
- On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to -$466000.0 in Q3 2023; TTM through Dec 2024 was -$466000.0, a 0.0% change from a year earlier, with the FY2023 full-year figure at $83.7 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased eased to -$466000.0 in Q3 2023 per SIBN's latest filing, from $71.6 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $71.6 million in Q4 2020 and bottomed at -$466000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 12.70 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | - |
| 10 | Si-Bone | 753.03 Mn | 608.35 Mn | 41.94 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -466,000.00 |
| Sep 30, 2023 | -466,000.00 |
| Dec 31, 2020 | 71.64 Mn |
| Dec 31, 2020 | 71.64 Mn |
| Mar 31, 2020 | 62.98 Mn |
| Mar 31, 2020 | 62.98 Mn |